← brief for 2026-09-09 · People & money

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Key takeaways

This is a registry, a long-term record of real patients with type 2 diabetes, high blood pressure, heart failure, or kidney disease. It tracks who they are, what care they get, how often they use the health system, and how they do over time. It is a data collection effort across many countries, not a test of any treatment. There are no results yet.

Who did this work

Run by AstraZeneca. Hardik Vasnawala, MD (AstraZeneca) · Isidro Villanueva, MD (AstraZeneca) · Ahmed Hadaoui, PharmD (AstraZeneca)
Sites: Research Site

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-09
https://clinicaltrials.gov/study/NCT03549754